3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
17
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
mogamulizumab
7
Specimen Handling
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
Biopsy
5
pembrolizumab
4
fludarabine
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
hypericin
3
fludarabine phosphate
3
cemiplimab
3
Radiotherapy
3
Nivolumab
3
sodium-iodide symporter
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Phototherapy
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Busulfan
2
talimogene laherparepvec
1
ruxolitinib
1
romidepsin
1
magrolimab
1
duvelisib
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
Sunitinib
×
1 year
×
Clear all
No trials found.